Gene Symbol | Gene ID | Gene Info |
---|---|---|
Atf3
|
ENSMUSG00000026628.8 | activating transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_191182430_191183982 | Atf3 | 98 | 0.955128 | 0.70 | 3.1e-09 | Click! |
chr1_191178777_191178928 | Atf3 | 4256 | 0.156850 | 0.57 | 6.3e-06 | Click! |
chr1_191193908_191194061 | Atf3 | 10644 | 0.132454 | 0.53 | 2.9e-05 | Click! |
chr1_191198028_191198179 | Atf3 | 14763 | 0.125946 | 0.44 | 8.6e-04 | Click! |
chr1_191194152_191194324 | Atf3 | 10898 | 0.132020 | 0.39 | 3.0e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 263.45 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr14_14354416_14355184 | 53.55 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr10_20518100_20518462 | 29.98 |
Gm17229 |
predicted gene 17229 |
117 |
0.97 |
chr10_20518494_20518668 | 27.70 |
Gm17229 |
predicted gene 17229 |
417 |
0.87 |
chr14_74490678_74490829 | 20.15 |
Gm49174 |
predicted gene, 49174 |
39194 |
0.15 |
chr14_74490931_74491126 | 20.07 |
Gm49174 |
predicted gene, 49174 |
39469 |
0.15 |
chr11_100938783_100940230 | 17.27 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr12_3238356_3238681 | 15.00 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
1907 |
0.28 |
chr14_14353319_14353777 | 14.62 |
Il3ra |
interleukin 3 receptor, alpha chain |
3927 |
0.13 |
chr9_61370339_61371660 | 12.93 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr8_84197696_84198961 | 11.72 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr19_5845343_5846183 | 11.54 |
Frmd8os |
FERM domain containing 8, opposite strand |
140 |
0.66 |
chr17_31855866_31856073 | 10.93 |
Sik1 |
salt inducible kinase 1 |
165 |
0.94 |
chr11_86586799_86587209 | 10.85 |
Vmp1 |
vacuole membrane protein 1 |
10 |
0.97 |
chr18_67745899_67746216 | 10.82 |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
21462 |
0.13 |
chr10_120914717_120915223 | 10.65 |
Gm16166 |
predicted gene 16166 |
13216 |
0.13 |
chr15_79690079_79691459 | 10.34 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr5_139796762_139798525 | 10.19 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
129 |
0.94 |
chr8_70698268_70700333 | 9.78 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr7_116503804_116504452 | 9.49 |
Nucb2 |
nucleobindin 2 |
241 |
0.9 |
chr3_79144987_79146081 | 9.45 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
341 |
0.91 |
chr2_173152672_173153088 | 9.41 |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
168 |
0.95 |
chr5_134919387_134919570 | 9.35 |
4933439J24Rik |
RIKEN cDNA 4933439J24 gene |
310 |
0.68 |
chr5_137786077_137787112 | 9.17 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr15_100599610_100600576 | 9.02 |
Pou6f1 |
POU domain, class 6, transcription factor 1 |
109 |
0.48 |
chr10_80141211_80141682 | 9.00 |
Atp5d |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
11 |
0.89 |
chr11_87126714_87127907 | 8.94 |
Trim37 |
tripartite motif-containing 37 |
5 |
0.84 |
chr8_114814959_114815324 | 8.87 |
Wwox |
WW domain-containing oxidoreductase |
102974 |
0.07 |
chr4_136143104_136143903 | 8.70 |
Id3 |
inhibitor of DNA binding 3 |
6 |
0.97 |
chr7_127768560_127769629 | 8.68 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr11_58953843_58955382 | 8.65 |
H2aw |
H2A.W histone |
73 |
0.33 |
chr16_92399556_92400502 | 8.41 |
Rcan1 |
regulator of calcineurin 1 |
48 |
0.97 |
chr5_109557850_109558797 | 8.34 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr7_114322801_114323522 | 8.18 |
Psma1 |
proteasome subunit alpha 1 |
47043 |
0.14 |
chr11_74837693_74838808 | 8.17 |
Mnt |
max binding protein |
782 |
0.52 |
chr17_71268038_71268559 | 8.16 |
Emilin2 |
elastin microfibril interfacer 2 |
299 |
0.88 |
chr4_134245189_134246001 | 8.09 |
Zfp593 |
zinc finger protein 593 |
3 |
0.93 |
chr13_37666246_37666836 | 8.00 |
AI463229 |
expressed sequence AI463229 |
1 |
0.96 |
chr4_102510968_102511183 | 7.89 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
40678 |
0.21 |
chr5_123057752_123058346 | 7.83 |
Gm6444 |
predicted gene 6444 |
8193 |
0.09 |
chr11_69096542_69097348 | 7.81 |
Per1 |
period circadian clock 1 |
1728 |
0.15 |
chr19_6132129_6132466 | 7.81 |
Snx15 |
sorting nexin 15 |
3993 |
0.07 |
chr3_121291927_121292619 | 7.74 |
Alg14 |
asparagine-linked glycosylation 14 |
383 |
0.82 |
chr5_137530580_137532081 | 7.73 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr1_86525613_86527056 | 7.71 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr12_17507244_17507446 | 7.70 |
Odc1 |
ornithine decarboxylase, structural 1 |
37449 |
0.12 |
chr1_170622997_170623376 | 7.69 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr2_166398944_166399580 | 7.69 |
Gm14268 |
predicted gene 14268 |
1075 |
0.58 |
chr11_115899580_115900578 | 7.68 |
Smim5 |
small integral membrane protein 5 |
99 |
0.93 |
chr11_68854163_68854424 | 7.67 |
Ndel1 |
nudE neurodevelopment protein 1 like 1 |
1158 |
0.39 |
chr6_83032753_83034325 | 7.62 |
Dok1 |
docking protein 1 |
68 |
0.86 |
chr11_60176319_60177391 | 7.62 |
Rai1 |
retinoic acid induced 1 |
976 |
0.44 |
chr11_69837611_69838644 | 7.60 |
Nlgn2 |
neuroligin 2 |
343 |
0.43 |
chr2_153161013_153161878 | 7.58 |
Tm9sf4 |
transmembrane 9 superfamily protein member 4 |
96 |
0.96 |
chr12_28805137_28805472 | 7.52 |
Gm48905 |
predicted gene, 48905 |
4834 |
0.19 |
chr10_128525093_128526268 | 7.51 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr12_72535708_72536908 | 7.47 |
Pcnx4 |
pecanex homolog 4 |
75 |
0.97 |
chr15_38543923_38544446 | 7.47 |
Azin1 |
antizyme inhibitor 1 |
24918 |
0.1 |
chr5_23850355_23851323 | 7.38 |
2700038G22Rik |
RIKEN cDNA 2700038G22 gene |
238 |
0.81 |
chr14_16447685_16448064 | 7.38 |
Top2b |
topoisomerase (DNA) II beta |
22446 |
0.21 |
chr14_20607892_20608043 | 7.34 |
Usp54 |
ubiquitin specific peptidase 54 |
2637 |
0.17 |
chr6_90622523_90623081 | 7.32 |
Slc41a3 |
solute carrier family 41, member 3 |
3655 |
0.17 |
chr14_65582082_65582447 | 7.31 |
Elp3 |
elongator acetyltransferase complex subunit 3 |
10786 |
0.21 |
chr2_28598572_28599148 | 7.17 |
Gm22675 |
predicted gene, 22675 |
3733 |
0.13 |
chr11_87749523_87749886 | 7.15 |
Mir142hg |
Mir142 host gene (non-protein coding) |
5873 |
0.09 |
chr16_32822096_32822289 | 7.11 |
Rubcn |
RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein |
2728 |
0.18 |
chr11_93995173_93995483 | 7.01 |
Spag9 |
sperm associated antigen 9 |
763 |
0.59 |
chr11_43569695_43570149 | 7.00 |
Gm12150 |
predicted gene 12150 |
11194 |
0.14 |
chr4_8689860_8690380 | 6.99 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
286 |
0.93 |
chr6_24597591_24597822 | 6.98 |
Lmod2 |
leiomodin 2 (cardiac) |
56 |
0.97 |
chr6_67161663_67162061 | 6.96 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr18_65025526_65026378 | 6.92 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
150 |
0.97 |
chr12_80114984_80115584 | 6.92 |
1300014J16Rik |
RIKEN cDNA 1300014J16 gene |
579 |
0.62 |
chr3_93597159_93597878 | 6.91 |
Gm5541 |
predicted gene 5541 |
32234 |
0.09 |
chr3_152549002_152549525 | 6.90 |
Ak5 |
adenylate kinase 5 |
22511 |
0.2 |
chr3_104762286_104762711 | 6.86 |
Gm6485 |
predicted gene 6485 |
9333 |
0.09 |
chr7_51632589_51633740 | 6.83 |
Gm45072 |
predicted gene 45072 |
1439 |
0.41 |
chr3_121530937_121531224 | 6.83 |
A530020G20Rik |
RIKEN cDNA A530020G20 gene |
539 |
0.67 |
chr12_82225804_82226178 | 6.81 |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
30594 |
0.19 |
chr10_121569006_121569830 | 6.76 |
Tbk1 |
TANK-binding kinase 1 |
937 |
0.48 |
chr9_46012271_46012911 | 6.74 |
Pafah1b2 |
platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 |
99 |
0.68 |
chr4_135876235_135877013 | 6.72 |
Pnrc2 |
proline-rich nuclear receptor coactivator 2 |
2774 |
0.15 |
chr2_26139656_26141133 | 6.71 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr12_24686000_24686681 | 6.69 |
Cys1 |
cystin 1 |
4527 |
0.16 |
chr1_152817059_152817770 | 6.69 |
Ncf2 |
neutrophil cytosolic factor 2 |
6155 |
0.16 |
chr10_69218728_69219039 | 6.66 |
Rhobtb1 |
Rho-related BTB domain containing 1 |
502 |
0.79 |
chr2_180303470_180303946 | 6.65 |
Rbbp8nl |
RBBP8 N-terminal like |
13829 |
0.11 |
chr2_167860263_167861115 | 6.64 |
Gm14319 |
predicted gene 14319 |
2104 |
0.29 |
chr5_143561547_143562201 | 6.61 |
Fam220a |
family with sequence similarity 220, member A |
12834 |
0.14 |
chr15_85935705_85936010 | 6.61 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
13435 |
0.17 |
chr9_58275148_58275533 | 6.61 |
Stoml1 |
stomatin-like 1 |
15113 |
0.13 |
chr4_139535052_139535706 | 6.57 |
Iffo2 |
intermediate filament family orphan 2 |
3690 |
0.22 |
chr1_34389196_34389610 | 6.56 |
Gm5266 |
predicted gene 5266 |
22032 |
0.09 |
chr1_91823488_91823892 | 6.55 |
Gm29101 |
predicted gene 29101 |
1175 |
0.47 |
chr1_24613351_24614205 | 6.54 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr5_96162084_96163134 | 6.47 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chr2_158127868_158128212 | 6.46 |
Gm20412 |
predicted gene 20412 |
10886 |
0.15 |
chr7_141146101_141146426 | 6.45 |
Ptdss2 |
phosphatidylserine synthase 2 |
8360 |
0.08 |
chr18_67369678_67370390 | 6.42 |
Tubb6 |
tubulin, beta 6 class V |
20683 |
0.13 |
chr11_119912951_119914125 | 6.40 |
Chmp6 |
charged multivesicular body protein 6 |
97 |
0.95 |
chr14_70074487_70075571 | 6.37 |
Egr3 |
early growth response 3 |
2174 |
0.25 |
chr6_138424907_138425582 | 6.36 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr11_30648868_30649937 | 6.34 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr16_30788522_30788755 | 6.30 |
Gm49754 |
predicted gene, 49754 |
4617 |
0.21 |
chr5_122143714_122143881 | 6.30 |
Ccdc63 |
coiled-coil domain containing 63 |
2974 |
0.18 |
chr1_127750694_127751059 | 6.27 |
Acmsd |
amino carboxymuconate semialdehyde decarboxylase |
5881 |
0.19 |
chr15_67146361_67146739 | 6.22 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
17527 |
0.24 |
chr4_150685000_150685176 | 6.20 |
Gm16079 |
predicted gene 16079 |
6296 |
0.22 |
chr9_111057150_111057866 | 6.20 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
11 |
0.95 |
chr12_40888538_40889137 | 6.18 |
Gm7239 |
predicted gene 7239 |
4223 |
0.18 |
chr2_75643190_75643507 | 6.14 |
Gm13655 |
predicted gene 13655 |
9966 |
0.14 |
chr3_60602746_60603521 | 6.14 |
Mbnl1 |
muscleblind like splicing factor 1 |
405 |
0.79 |
chr5_100860654_100861040 | 6.12 |
4930458D05Rik |
RIKEN cDNA 4930458D05 gene |
13680 |
0.1 |
chr13_101573406_101573557 | 6.11 |
Gm19010 |
predicted gene, 19010 |
15650 |
0.16 |
chr19_32181834_32182000 | 6.09 |
Sgms1 |
sphingomyelin synthase 1 |
14511 |
0.21 |
chr7_120865040_120865504 | 6.08 |
Gm15774 |
predicted gene 15774 |
10026 |
0.13 |
chr1_86527639_86529135 | 6.00 |
Ptma |
prothymosin alpha |
1580 |
0.31 |
chr11_78535469_78535809 | 5.98 |
Tnfaip1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
632 |
0.35 |
chr2_35589940_35590249 | 5.97 |
Dab2ip |
disabled 2 interacting protein |
7254 |
0.2 |
chr11_117780842_117781082 | 5.96 |
Tmc6 |
transmembrane channel-like gene family 6 |
18 |
0.93 |
chr15_3247489_3247792 | 5.95 |
Selenop |
selenoprotein P |
20907 |
0.18 |
chr1_191277526_191278108 | 5.95 |
Gm37168 |
predicted gene, 37168 |
10639 |
0.13 |
chrX_123943434_123943951 | 5.92 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr4_86886186_86886590 | 5.92 |
Acer2 |
alkaline ceramidase 2 |
11974 |
0.21 |
chrX_123721926_123722462 | 5.90 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chr9_41105452_41105603 | 5.89 |
Gm48611 |
predicted gene, 48611 |
6554 |
0.17 |
chr1_181323221_181323527 | 5.89 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
29254 |
0.13 |
chr3_103171228_103172264 | 5.86 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr11_48873308_48874023 | 5.85 |
Irgm1 |
immunity-related GTPase family M member 1 |
1982 |
0.19 |
chr3_79994303_79994554 | 5.85 |
A330069K06Rik |
RIKEN cDNA A330069K06 gene |
60464 |
0.11 |
chr2_156494879_156495181 | 5.81 |
Epb41l1 |
erythrocyte membrane protein band 4.1 like 1 |
11364 |
0.13 |
chr4_133552955_133553552 | 5.78 |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
123 |
0.92 |
chr5_28036647_28036798 | 5.78 |
Gm43611 |
predicted gene 43611 |
316 |
0.87 |
chr12_12428481_12428871 | 5.78 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
36061 |
0.21 |
chr6_140646969_140647174 | 5.78 |
Aebp2 |
AE binding protein 2 |
254 |
0.93 |
chr5_140644792_140645130 | 5.76 |
Ttyh3 |
tweety family member 3 |
4036 |
0.17 |
chr5_76828559_76829372 | 5.76 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
11634 |
0.19 |
chr9_21161428_21161668 | 5.75 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
4166 |
0.12 |
chr1_189860190_189860566 | 5.74 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
2281 |
0.23 |
chr1_74007725_74008174 | 5.71 |
Tns1 |
tensin 1 |
6382 |
0.25 |
chr13_58215850_58216388 | 5.70 |
Ubqln1 |
ubiquilin 1 |
466 |
0.68 |
chr8_107095919_107096832 | 5.68 |
Terf2 |
telomeric repeat binding factor 2 |
139 |
0.66 |
chr6_113644916_113645098 | 5.68 |
Gm43964 |
predicted gene, 43964 |
3486 |
0.09 |
chr16_42676780_42676965 | 5.67 |
Gm49739 |
predicted gene, 49739 |
12946 |
0.29 |
chr6_115852875_115853903 | 5.66 |
Mbd4 |
methyl-CpG binding domain protein 4 |
18 |
0.55 |
chr11_69854050_69854225 | 5.65 |
Tnk1 |
tyrosine kinase, non-receptor, 1 |
1465 |
0.14 |
chr2_165884402_165885933 | 5.64 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr14_25527404_25527588 | 5.64 |
Mir3075 |
microRNA 3075 |
6943 |
0.17 |
chr11_106976225_106976547 | 5.64 |
Gm11707 |
predicted gene 11707 |
3296 |
0.18 |
chr8_122546722_122547355 | 5.63 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
4291 |
0.11 |
chr18_6275505_6275996 | 5.63 |
Kif5b |
kinesin family member 5B |
33576 |
0.13 |
chr5_118981037_118981522 | 5.62 |
Gm43784 |
predicted gene 43784 |
15717 |
0.19 |
chr12_73779331_73779528 | 5.62 |
Gm8075 |
predicted gene 8075 |
14054 |
0.2 |
chr11_107529395_107529646 | 5.61 |
C330019F10Rik |
RIKEN cDNA C330019F10 gene |
2300 |
0.19 |
chr10_62327543_62328005 | 5.61 |
Hk1 |
hexokinase 1 |
7 |
0.97 |
chr6_134792560_134793349 | 5.61 |
Dusp16 |
dual specificity phosphatase 16 |
329 |
0.85 |
chr11_19924323_19926342 | 5.61 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr12_112488364_112488832 | 5.60 |
A530016L24Rik |
RIKEN cDNA A530016L24 gene |
850 |
0.56 |
chr16_87306949_87307599 | 5.60 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
46911 |
0.15 |
chr7_16781038_16782438 | 5.60 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
370 |
0.78 |
chrX_123500550_123501093 | 5.60 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr11_103051357_103051595 | 5.59 |
Plcd3 |
phospholipase C, delta 3 |
20274 |
0.1 |
chr10_86025984_86026319 | 5.57 |
A230060F14Rik |
RIKEN cDNA A230060F14 gene |
3822 |
0.13 |
chr3_37903598_37903749 | 5.56 |
Gm20755 |
predicted gene, 20755 |
4860 |
0.19 |
chr17_84119683_84119888 | 5.55 |
Gm19696 |
predicted gene, 19696 |
16175 |
0.15 |
chr10_69916525_69916676 | 5.55 |
Ank3 |
ankyrin 3, epithelial |
1735 |
0.52 |
chr13_60936561_60936921 | 5.54 |
Ctla2a |
cytotoxic T lymphocyte-associated protein 2 alpha |
116 |
0.55 |
chr12_72437630_72438246 | 5.53 |
Lrrc9 |
leucine rich repeat containing 9 |
3928 |
0.24 |
chr6_86471867_86472650 | 5.52 |
C87436 |
expressed sequence C87436 |
8218 |
0.08 |
chr14_121137210_121137664 | 5.51 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
35358 |
0.2 |
chr4_129513695_129514851 | 5.51 |
Marcksl1 |
MARCKS-like 1 |
692 |
0.46 |
chr13_94037415_94037843 | 5.50 |
Cycs-ps3 |
cytochrome c, pseudogene 3 |
16214 |
0.17 |
chr17_34836344_34837687 | 5.49 |
Dxo |
decapping exoribonuclease |
4 |
0.52 |
chr19_56286912_56287249 | 5.49 |
Habp2 |
hyaluronic acid binding protein 2 |
57 |
0.98 |
chr4_114627667_114628212 | 5.48 |
Gm28864 |
predicted gene 28864 |
45401 |
0.16 |
chr18_80631263_80631965 | 5.47 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
22639 |
0.16 |
chr9_45201620_45201847 | 5.46 |
Tmprss4 |
transmembrane protease, serine 4 |
2253 |
0.17 |
chr9_108338578_108339700 | 5.46 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr9_21715298_21715606 | 5.46 |
Gm26511 |
predicted gene, 26511 |
7998 |
0.13 |
chr7_19227944_19228418 | 5.45 |
Opa3 |
optic atrophy 3 |
153 |
0.89 |
chr17_86769683_86769869 | 5.43 |
Gm50008 |
predicted gene, 50008 |
3494 |
0.23 |
chr7_111179367_111179913 | 5.42 |
1700012D14Rik |
RIKEN cDNA 1700012D14 gene |
56956 |
0.11 |
chr9_106170484_106171031 | 5.41 |
Wdr82 |
WD repeat domain containing 82 |
171 |
0.89 |
chr19_53080891_53081464 | 5.41 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chrX_10714525_10715126 | 5.41 |
Mid1ip1 |
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) |
188 |
0.93 |
chr7_17059591_17061170 | 5.39 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1846 |
0.19 |
chr7_34313450_34313926 | 5.39 |
4931406P16Rik |
RIKEN cDNA 4931406P16 gene |
137 |
0.94 |
chr13_44663056_44663676 | 5.37 |
Gm47805 |
predicted gene, 47805 |
41184 |
0.16 |
chr1_135731863_135732606 | 5.37 |
Csrp1 |
cysteine and glycine-rich protein 1 |
3087 |
0.22 |
chr3_157732464_157732921 | 5.37 |
Gm33466 |
predicted gene, 33466 |
6284 |
0.26 |
chr2_103480341_103480729 | 5.36 |
Cat |
catalase |
4590 |
0.21 |
chr11_21415186_21415480 | 5.35 |
Gm12044 |
predicted gene 12044 |
36021 |
0.11 |
chr5_137921592_137921941 | 5.35 |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
147 |
0.9 |
chr9_71317207_71317372 | 5.33 |
Gm48124 |
predicted gene, 48124 |
38104 |
0.18 |
chr6_83053374_83054579 | 5.33 |
Htra2 |
HtrA serine peptidase 2 |
61 |
0.84 |
chr15_25940377_25941010 | 5.32 |
Retreg1 |
reticulophagy regulator 1 |
9 |
0.98 |
chr7_128854217_128854571 | 5.32 |
Gm25778 |
predicted gene, 25778 |
28047 |
0.15 |
chr3_127930721_127931028 | 5.30 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14702 |
0.14 |
chr13_44733414_44734122 | 5.30 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
272 |
0.94 |
chr7_110088063_110088458 | 5.28 |
Zfp143 |
zinc finger protein 143 |
3369 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 23.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
5.5 | 16.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
4.8 | 9.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
4.6 | 4.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
4.5 | 13.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
4.4 | 13.1 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
4.3 | 13.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
4.2 | 12.6 | GO:0002432 | granuloma formation(GO:0002432) |
3.9 | 19.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
3.9 | 15.6 | GO:0003166 | bundle of His development(GO:0003166) |
3.9 | 7.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
3.8 | 11.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
3.8 | 11.5 | GO:0002086 | diaphragm contraction(GO:0002086) |
3.8 | 11.4 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
3.8 | 3.8 | GO:0090075 | relaxation of cardiac muscle(GO:0055119) relaxation of muscle(GO:0090075) regulation of relaxation of cardiac muscle(GO:1901897) |
3.7 | 14.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
3.7 | 18.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
3.6 | 7.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
3.6 | 10.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
3.6 | 14.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
3.5 | 17.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
3.3 | 6.7 | GO:0008228 | opsonization(GO:0008228) |
3.3 | 9.9 | GO:0040031 | snRNA modification(GO:0040031) |
3.3 | 6.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
3.3 | 16.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
3.2 | 12.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
3.2 | 6.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
3.2 | 16.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
3.2 | 16.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
3.2 | 9.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.2 | 3.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
3.1 | 9.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.1 | 9.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
3.1 | 6.3 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
3.1 | 9.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
3.1 | 9.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
3.1 | 9.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.0 | 9.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.0 | 3.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
3.0 | 11.8 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
2.9 | 11.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
2.9 | 11.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
2.9 | 8.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.9 | 2.9 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
2.9 | 23.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
2.9 | 8.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
2.8 | 14.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.8 | 11.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.8 | 8.4 | GO:0072553 | terminal button organization(GO:0072553) |
2.8 | 8.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.8 | 8.3 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.7 | 8.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
2.7 | 2.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
2.7 | 2.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
2.7 | 13.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.7 | 16.0 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
2.6 | 7.9 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.6 | 7.9 | GO:0042117 | monocyte activation(GO:0042117) |
2.6 | 5.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
2.6 | 2.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
2.6 | 12.9 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
2.6 | 12.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.6 | 10.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
2.6 | 7.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.6 | 5.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
2.5 | 2.5 | GO:0070814 | hydrogen sulfide metabolic process(GO:0070813) hydrogen sulfide biosynthetic process(GO:0070814) |
2.5 | 7.6 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
2.5 | 17.8 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
2.5 | 2.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.5 | 5.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
2.5 | 25.3 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
2.5 | 9.9 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
2.5 | 7.4 | GO:0050904 | diapedesis(GO:0050904) |
2.5 | 7.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.4 | 7.3 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
2.4 | 4.9 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
2.4 | 7.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
2.4 | 2.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
2.4 | 2.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.4 | 7.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.4 | 28.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
2.4 | 4.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
2.4 | 9.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.4 | 16.6 | GO:0046060 | dATP metabolic process(GO:0046060) |
2.4 | 18.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
2.4 | 14.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
2.3 | 9.4 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
2.3 | 7.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.3 | 11.6 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
2.3 | 4.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.3 | 11.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
2.3 | 4.6 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.3 | 9.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
2.3 | 2.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
2.3 | 4.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.3 | 6.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.3 | 6.8 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.2 | 9.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
2.2 | 4.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
2.2 | 8.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.2 | 2.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
2.2 | 6.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.2 | 6.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
2.2 | 55.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.2 | 6.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
2.2 | 2.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
2.2 | 8.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
2.2 | 2.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
2.2 | 8.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
2.2 | 4.3 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
2.2 | 4.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.1 | 2.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.1 | 4.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.1 | 6.3 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
2.1 | 2.1 | GO:0030035 | microspike assembly(GO:0030035) |
2.1 | 6.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.1 | 6.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.1 | 2.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.1 | 6.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.1 | 6.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
2.1 | 6.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.1 | 6.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.0 | 2.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
2.0 | 12.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.0 | 14.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
2.0 | 6.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
2.0 | 16.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
2.0 | 8.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
2.0 | 18.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
2.0 | 6.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.0 | 22.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
2.0 | 4.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
2.0 | 6.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.0 | 8.0 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
2.0 | 6.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.0 | 11.9 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
2.0 | 7.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.0 | 7.9 | GO:0043379 | memory T cell differentiation(GO:0043379) |
2.0 | 5.9 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
2.0 | 3.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
2.0 | 5.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
2.0 | 15.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.9 | 5.8 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.9 | 9.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.9 | 21.4 | GO:0030575 | nuclear body organization(GO:0030575) |
1.9 | 31.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.9 | 1.9 | GO:0035973 | aggrephagy(GO:0035973) |
1.9 | 5.8 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.9 | 5.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.9 | 5.7 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.9 | 5.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.9 | 3.8 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.9 | 3.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.9 | 3.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.9 | 7.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.9 | 5.6 | GO:0045636 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
1.9 | 1.9 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.9 | 1.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.9 | 7.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.9 | 1.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.8 | 5.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.8 | 5.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.8 | 3.7 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.8 | 1.8 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
1.8 | 3.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.8 | 1.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.8 | 3.6 | GO:0032439 | endosome localization(GO:0032439) |
1.8 | 5.5 | GO:0000087 | mitotic M phase(GO:0000087) |
1.8 | 7.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
1.8 | 5.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.8 | 5.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
1.8 | 3.6 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
1.8 | 1.8 | GO:0003032 | detection of oxygen(GO:0003032) |
1.8 | 1.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.8 | 5.4 | GO:0008050 | female courtship behavior(GO:0008050) |
1.8 | 9.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.8 | 7.2 | GO:0007296 | vitellogenesis(GO:0007296) |
1.8 | 19.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.8 | 23.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.8 | 5.3 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
1.8 | 1.8 | GO:1904292 | regulation of ERAD pathway(GO:1904292) positive regulation of ERAD pathway(GO:1904294) |
1.8 | 5.3 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.8 | 1.8 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
1.8 | 3.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.8 | 5.3 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.8 | 21.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.8 | 3.5 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.7 | 5.2 | GO:0043622 | cortical microtubule organization(GO:0043622) |
1.7 | 5.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.7 | 3.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.7 | 7.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.7 | 10.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.7 | 12.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.7 | 1.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.7 | 5.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.7 | 6.9 | GO:0006116 | NADH oxidation(GO:0006116) |
1.7 | 5.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.7 | 12.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.7 | 1.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.7 | 5.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.7 | 1.7 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
1.7 | 18.9 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.7 | 5.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.7 | 11.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.7 | 8.5 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.7 | 6.8 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
1.7 | 5.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.7 | 1.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.7 | 6.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.7 | 13.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.7 | 5.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.7 | 10.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.7 | 11.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.7 | 6.6 | GO:0015793 | glycerol transport(GO:0015793) |
1.7 | 5.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.7 | 38.1 | GO:0014823 | response to activity(GO:0014823) |
1.7 | 18.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.7 | 3.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.6 | 11.5 | GO:0015825 | L-serine transport(GO:0015825) |
1.6 | 9.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.6 | 1.6 | GO:0002176 | male germ cell proliferation(GO:0002176) |
1.6 | 6.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.6 | 19.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.6 | 6.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.6 | 4.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.6 | 6.5 | GO:0070836 | caveola assembly(GO:0070836) |
1.6 | 3.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
1.6 | 8.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.6 | 8.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.6 | 12.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.6 | 4.8 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.6 | 9.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.6 | 3.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.6 | 8.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.6 | 4.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.6 | 4.8 | GO:0009838 | abscission(GO:0009838) |
1.6 | 8.0 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.6 | 6.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.6 | 1.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.6 | 4.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.6 | 1.6 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
1.6 | 1.6 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
1.6 | 4.8 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
1.6 | 6.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
1.6 | 3.2 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
1.6 | 4.8 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.6 | 9.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.6 | 19.1 | GO:0006907 | pinocytosis(GO:0006907) |
1.6 | 6.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.6 | 4.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.6 | 1.6 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
1.6 | 4.7 | GO:0015886 | heme transport(GO:0015886) |
1.6 | 4.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.6 | 6.3 | GO:0051031 | tRNA transport(GO:0051031) |
1.6 | 1.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.6 | 1.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.6 | 4.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.6 | 7.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.5 | 1.5 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.5 | 1.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.5 | 4.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.5 | 12.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.5 | 4.6 | GO:0032782 | bile acid secretion(GO:0032782) |
1.5 | 4.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.5 | 1.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.5 | 4.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.5 | 1.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.5 | 10.6 | GO:0030049 | muscle filament sliding(GO:0030049) |
1.5 | 6.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.5 | 22.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.5 | 1.5 | GO:0010390 | histone monoubiquitination(GO:0010390) |
1.5 | 6.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.5 | 1.5 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
1.5 | 6.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
1.5 | 6.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.5 | 4.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.5 | 13.5 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
1.5 | 7.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.5 | 7.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.5 | 13.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.5 | 8.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.5 | 3.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.5 | 2.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.5 | 7.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.5 | 2.9 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
1.5 | 5.8 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.5 | 4.4 | GO:0018343 | protein farnesylation(GO:0018343) |
1.5 | 1.5 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.4 | 27.5 | GO:0048821 | erythrocyte development(GO:0048821) |
1.4 | 7.2 | GO:0097459 | iron ion import into cell(GO:0097459) |
1.4 | 10.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.4 | 5.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.4 | 4.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.4 | 2.9 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.4 | 4.3 | GO:0080009 | mRNA methylation(GO:0080009) |
1.4 | 4.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.4 | 8.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.4 | 5.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.4 | 2.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.4 | 2.8 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.4 | 9.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.4 | 7.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.4 | 5.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.4 | 2.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.4 | 5.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.4 | 5.6 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.4 | 2.8 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
1.4 | 8.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.4 | 4.2 | GO:0033483 | gas homeostasis(GO:0033483) |
1.4 | 2.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.4 | 5.6 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
1.4 | 4.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
1.4 | 9.8 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
1.4 | 2.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.4 | 11.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.4 | 2.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.4 | 1.4 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.4 | 4.1 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.4 | 9.7 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
1.4 | 9.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.4 | 5.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.4 | 9.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.4 | 11.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.4 | 2.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.4 | 8.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.4 | 9.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
1.4 | 4.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
1.4 | 5.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.4 | 2.7 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.4 | 1.4 | GO:0021590 | cerebellum maturation(GO:0021590) |
1.4 | 1.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.4 | 4.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.3 | 2.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.3 | 4.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
1.3 | 6.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.3 | 5.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.3 | 6.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.3 | 4.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.3 | 2.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.3 | 14.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.3 | 1.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.3 | 2.7 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
1.3 | 1.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.3 | 4.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.3 | 4.0 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
1.3 | 5.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.3 | 5.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.3 | 4.0 | GO:0015871 | choline transport(GO:0015871) |
1.3 | 5.3 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
1.3 | 2.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
1.3 | 6.6 | GO:0048539 | bone marrow development(GO:0048539) |
1.3 | 13.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.3 | 3.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.3 | 3.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.3 | 2.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.3 | 2.6 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
1.3 | 2.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.3 | 2.6 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
1.3 | 1.3 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
1.3 | 3.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.3 | 6.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.3 | 6.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.3 | 11.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.3 | 7.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.3 | 1.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.3 | 2.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.3 | 3.9 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.3 | 7.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.3 | 3.8 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
1.3 | 3.8 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
1.3 | 7.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.3 | 7.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.3 | 3.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.3 | 3.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.3 | 1.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.3 | 2.5 | GO:0097286 | iron ion import(GO:0097286) |
1.3 | 2.5 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
1.3 | 6.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.3 | 1.3 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
1.3 | 5.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.3 | 2.5 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.3 | 1.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.2 | 7.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.2 | 13.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.2 | 1.2 | GO:0070384 | Harderian gland development(GO:0070384) |
1.2 | 1.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.2 | 2.5 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
1.2 | 3.7 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
1.2 | 2.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.2 | 7.4 | GO:0060613 | fat pad development(GO:0060613) |
1.2 | 2.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.2 | 1.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.2 | 1.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.2 | 1.2 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.2 | 9.8 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
1.2 | 1.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.2 | 8.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.2 | 1.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
1.2 | 8.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.2 | 2.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.2 | 2.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.2 | 4.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.2 | 7.3 | GO:0050779 | RNA destabilization(GO:0050779) |
1.2 | 4.8 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
1.2 | 8.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.2 | 9.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.2 | 1.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.2 | 4.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.2 | 4.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.2 | 2.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.2 | 2.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
1.2 | 2.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.2 | 9.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.2 | 6.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.2 | 4.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.2 | 2.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.2 | 2.4 | GO:0042938 | dipeptide transport(GO:0042938) |
1.2 | 4.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.2 | 2.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.2 | 1.2 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) very-low-density lipoprotein particle clearance(GO:0034447) |
1.2 | 3.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.2 | 5.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.2 | 3.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.2 | 3.5 | GO:0015744 | succinate transport(GO:0015744) |
1.2 | 4.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.2 | 3.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.2 | 2.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
1.2 | 2.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.2 | 2.3 | GO:0036166 | phenotypic switching(GO:0036166) |
1.2 | 3.5 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.2 | 12.9 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
1.2 | 7.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.2 | 1.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.2 | 2.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.2 | 2.3 | GO:0002434 | immune complex clearance(GO:0002434) |
1.2 | 3.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.2 | 1.2 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
1.2 | 9.2 | GO:0051601 | exocyst localization(GO:0051601) |
1.2 | 1.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.2 | 9.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.2 | 1.2 | GO:0070988 | demethylation(GO:0070988) |
1.2 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.1 | 9.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.1 | 2.3 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.1 | 9.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.1 | 1.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
1.1 | 1.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
1.1 | 9.0 | GO:0007097 | nuclear migration(GO:0007097) |
1.1 | 7.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.1 | 3.4 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.1 | 6.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.1 | 3.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.1 | 2.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.1 | 4.5 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
1.1 | 30.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
1.1 | 4.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.1 | 1.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.1 | 2.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.1 | 1.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.1 | 1.1 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
1.1 | 1.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.1 | 11.0 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
1.1 | 12.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.1 | 3.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.1 | 4.4 | GO:0003383 | apical constriction(GO:0003383) |
1.1 | 25.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
1.1 | 7.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
1.1 | 2.2 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
1.1 | 1.1 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
1.1 | 4.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.1 | 5.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.1 | 1.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
1.1 | 8.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.1 | 3.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.1 | 1.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
1.1 | 11.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.1 | 1.1 | GO:0061184 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) positive regulation of dermatome development(GO:0061184) |
1.1 | 2.2 | GO:0009750 | response to fructose(GO:0009750) |
1.1 | 4.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.1 | 9.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
1.1 | 1.1 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
1.1 | 3.2 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.1 | 3.2 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.1 | 2.1 | GO:0051593 | response to folic acid(GO:0051593) |
1.1 | 4.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
1.1 | 1.1 | GO:0034204 | lipid translocation(GO:0034204) |
1.1 | 3.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.1 | 3.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.1 | 1.1 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
1.1 | 1.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.1 | 2.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.1 | 1.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.1 | 1.1 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.1 | 2.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
1.1 | 1.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.1 | 2.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.1 | 1.1 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.1 | 1.1 | GO:0002215 | defense response to nematode(GO:0002215) |
1.1 | 3.2 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.0 | 4.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.0 | 4.2 | GO:0018101 | protein citrullination(GO:0018101) |
1.0 | 12.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
1.0 | 2.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.0 | 3.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.0 | 4.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.0 | 12.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.0 | 2.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.0 | 1.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.0 | 3.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.0 | 4.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.0 | 3.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.0 | 8.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.0 | 5.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.0 | 3.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.0 | 3.1 | GO:0061010 | gall bladder development(GO:0061010) |
1.0 | 4.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.0 | 8.2 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
1.0 | 4.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.0 | 2.0 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
1.0 | 4.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.0 | 3.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
1.0 | 4.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.0 | 1.0 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.0 | 5.1 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
1.0 | 2.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.0 | 5.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.0 | 2.0 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.0 | 12.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.0 | 7.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.0 | 11.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
1.0 | 19.2 | GO:0006301 | postreplication repair(GO:0006301) |
1.0 | 3.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
1.0 | 1.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.0 | 2.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.0 | 1.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.0 | 1.0 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
1.0 | 4.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.0 | 3.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.0 | 3.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.0 | 1.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
1.0 | 7.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.0 | 5.9 | GO:0051639 | actin filament network formation(GO:0051639) |
1.0 | 11.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
1.0 | 4.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.0 | 3.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
1.0 | 1.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.0 | 3.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.0 | 3.9 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
1.0 | 2.9 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.0 | 2.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.0 | 3.9 | GO:0032570 | response to progesterone(GO:0032570) |
1.0 | 1.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.0 | 2.9 | GO:0060056 | mammary gland involution(GO:0060056) |
1.0 | 4.9 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
1.0 | 2.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.0 | 17.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.0 | 2.0 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.0 | 2.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
1.0 | 1.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.0 | 4.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.0 | 9.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.0 | 4.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.0 | 1.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.0 | 4.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.0 | 2.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.0 | 1.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.0 | 1.0 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
1.0 | 4.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.0 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.0 | 1.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.0 | 2.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.0 | 4.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.0 | 3.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.0 | 6.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.0 | 6.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.0 | 1.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.0 | 1.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.0 | 2.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.0 | 1.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.0 | 1.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.0 | 2.9 | GO:0015671 | oxygen transport(GO:0015671) |
1.0 | 3.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.0 | 1.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.9 | 0.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.9 | 4.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.9 | 1.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.9 | 1.9 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.9 | 1.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.9 | 2.8 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.9 | 2.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.9 | 1.9 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.9 | 1.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.9 | 0.9 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.9 | 2.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.9 | 0.9 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.9 | 3.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.9 | 0.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.9 | 20.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.9 | 1.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.9 | 2.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.9 | 0.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.9 | 12.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.9 | 5.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 1.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.9 | 2.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.9 | 3.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.9 | 4.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.9 | 5.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.9 | 3.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.9 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.9 | 1.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.9 | 0.9 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.9 | 1.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.9 | 3.7 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.9 | 11.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.9 | 9.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.9 | 0.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.9 | 2.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.9 | 1.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.9 | 5.5 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.9 | 6.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.9 | 7.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.9 | 4.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.9 | 2.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.9 | 3.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.9 | 4.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.9 | 3.6 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.9 | 0.9 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.9 | 12.7 | GO:0043486 | histone exchange(GO:0043486) |
0.9 | 0.9 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.9 | 0.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.9 | 1.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.9 | 6.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.9 | 0.9 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.9 | 8.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.9 | 5.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.9 | 3.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.9 | 0.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.9 | 1.8 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.9 | 3.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.9 | 2.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.9 | 8.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.9 | 18.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.9 | 3.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.9 | 1.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.9 | 1.8 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.9 | 1.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.9 | 4.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.9 | 1.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.9 | 6.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.9 | 10.6 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.9 | 13.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.9 | 1.8 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.9 | 7.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.9 | 7.9 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.9 | 2.6 | GO:0006826 | iron ion transport(GO:0006826) |
0.9 | 10.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.9 | 0.9 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.9 | 1.7 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.9 | 0.9 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.9 | 0.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.9 | 3.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.9 | 13.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.9 | 1.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.9 | 6.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.9 | 6.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.9 | 4.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.9 | 3.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.9 | 1.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.9 | 2.6 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.9 | 2.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.9 | 4.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.9 | 1.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.9 | 1.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 10.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.9 | 0.9 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.9 | 1.7 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.9 | 6.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.9 | 10.2 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.9 | 6.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.9 | 1.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.9 | 0.9 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.9 | 3.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.9 | 11.9 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.9 | 3.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.9 | 28.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.8 | 0.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.8 | 5.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.8 | 5.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.8 | 0.8 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.8 | 3.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.8 | 1.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.8 | 2.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 11.8 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.8 | 0.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 6.7 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.8 | 2.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.8 | 0.8 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.8 | 12.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.8 | 2.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.8 | 2.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.8 | 4.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.8 | 10.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.8 | 5.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.8 | 4.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.8 | 0.8 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.8 | 2.5 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.8 | 3.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.8 | 2.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.8 | 2.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.8 | 6.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.8 | 4.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.8 | 2.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.8 | 2.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.8 | 1.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.8 | 1.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.8 | 1.6 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.8 | 6.5 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.8 | 4.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.8 | 8.9 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.8 | 1.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.8 | 1.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.8 | 0.8 | GO:0006415 | translational termination(GO:0006415) |
0.8 | 3.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.8 | 4.8 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.8 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.8 | 1.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.8 | 1.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.8 | 3.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.8 | 10.4 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.8 | 1.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.8 | 0.8 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.8 | 2.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.8 | 3.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.8 | 5.5 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.8 | 4.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.8 | 1.6 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.8 | 0.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.8 | 2.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.8 | 4.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.8 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 3.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.8 | 27.9 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.8 | 3.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.8 | 2.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.8 | 2.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.8 | 4.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.8 | 7.7 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.8 | 1.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.8 | 11.5 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.8 | 3.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.8 | 0.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.8 | 2.3 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.8 | 21.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.8 | 2.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.8 | 10.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.8 | 15.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.8 | 6.1 | GO:0046697 | decidualization(GO:0046697) |
0.8 | 1.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.8 | 0.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.8 | 12.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.8 | 2.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.8 | 3.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.8 | 3.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.8 | 2.3 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 6.0 | GO:0043297 | apical junction assembly(GO:0043297) |
0.7 | 3.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.7 | 4.5 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.7 | 0.7 | GO:0033058 | directional locomotion(GO:0033058) |
0.7 | 1.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.7 | 2.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.7 | 2.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.7 | 3.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.7 | 2.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.7 | 2.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 3.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.7 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.7 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 1.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.7 | 0.7 | GO:0002576 | platelet degranulation(GO:0002576) |
0.7 | 2.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.7 | 2.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.7 | 1.5 | GO:0046909 | intermembrane transport(GO:0046909) |
0.7 | 7.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.7 | 0.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 4.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.7 | 2.2 | GO:0042168 | heme metabolic process(GO:0042168) |
0.7 | 4.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 8.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.7 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 1.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.7 | 1.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.7 | 1.4 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.7 | 5.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.7 | 0.7 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.7 | 5.0 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.7 | 2.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 8.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.7 | 1.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.7 | 1.4 | GO:0046931 | pore complex assembly(GO:0046931) |
0.7 | 2.8 | GO:0009118 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.7 | 1.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.7 | 4.9 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.7 | 6.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.7 | 1.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 0.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.7 | 4.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.7 | 3.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.7 | 3.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.7 | 2.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.7 | 1.4 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.7 | 8.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.7 | 1.4 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.7 | 2.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.7 | 13.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.7 | 3.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.7 | 4.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.7 | 4.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.7 | 3.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.7 | 0.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.7 | 2.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.7 | 2.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.7 | 11.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.7 | 1.4 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.7 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.7 | 5.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.7 | 2.8 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.7 | 6.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.7 | 19.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.7 | 1.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.7 | 0.7 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.7 | 2.1 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.7 | 1.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 4.8 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.7 | 1.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.7 | 1.4 | GO:0060068 | vagina development(GO:0060068) |
0.7 | 2.7 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.7 | 2.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.7 | 8.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.7 | 1.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.7 | 1.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.7 | 2.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.7 | 1.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.7 | 4.7 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.7 | 1.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.7 | 2.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.7 | 2.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.7 | 0.7 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.7 | 9.4 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.7 | 10.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.7 | 2.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.7 | 4.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.7 | 0.7 | GO:0050955 | thermoception(GO:0050955) |
0.7 | 9.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.7 | 0.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.7 | 7.2 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.7 | 2.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 2.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.7 | 17.1 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.7 | 1.3 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.7 | 1.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 5.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.7 | 0.7 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.7 | 1.3 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.7 | 0.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.7 | 8.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.7 | 1.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.6 | 3.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 14.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 1.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.6 | 5.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.6 | 1.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.6 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 3.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.6 | 1.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.6 | 2.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 5.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.6 | 3.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.6 | 3.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.6 | 1.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 0.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.6 | 9.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.6 | 2.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 1.3 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.6 | 5.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.6 | 2.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.6 | 6.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.6 | 3.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.6 | 12.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.6 | 1.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.6 | 9.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.6 | 1.2 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.6 | 0.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.6 | 7.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.6 | 6.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.6 | 1.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.6 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.6 | 1.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.6 | 1.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.6 | 1.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.6 | 2.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.6 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 1.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.6 | 1.2 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.6 | 2.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.6 | 3.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.6 | 1.8 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.6 | 0.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.6 | 0.6 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.6 | 4.2 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.6 | 1.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.6 | 16.9 | GO:0042073 | intraciliary transport(GO:0042073) |
0.6 | 3.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 4.8 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.6 | 0.6 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.6 | 1.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.6 | 1.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.6 | 1.8 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 1.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.6 | 6.6 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.6 | 1.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 1.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.6 | 13.8 | GO:0007569 | cell aging(GO:0007569) |
0.6 | 4.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.6 | 1.2 | GO:0015669 | gas transport(GO:0015669) |
0.6 | 0.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.6 | 1.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.6 | 0.6 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.6 | 0.6 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.6 | 1.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.6 | 0.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.6 | 1.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.6 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 1.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.6 | 1.8 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.6 | 1.2 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.6 | 4.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.6 | 1.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 14.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.6 | 2.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.6 | 0.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 1.2 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.6 | 0.6 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.6 | 3.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.6 | 2.9 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.6 | 3.5 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.6 | 2.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.6 | 1.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.6 | 2.9 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.6 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 1.7 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.6 | 2.9 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.6 | 1.7 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.6 | 1.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.6 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.6 | 1.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.6 | 5.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.6 | 5.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.6 | 4.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.6 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.6 | 1.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.6 | 2.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 1.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 0.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.6 | 1.7 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.6 | 3.9 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.6 | 1.1 | GO:0009597 | detection of virus(GO:0009597) |
0.6 | 0.6 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.6 | 3.3 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.6 | 1.7 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.6 | 2.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.6 | 7.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.6 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 7.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.6 | 1.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.6 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.6 | 7.2 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.6 | 1.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.6 | 3.9 | GO:0006560 | proline metabolic process(GO:0006560) |
0.6 | 0.6 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.6 | 4.4 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.6 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.5 | 1.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.5 | 1.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 2.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.5 | 2.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 0.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.5 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.5 | 1.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.5 | 4.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.5 | 1.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 0.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.5 | 5.4 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.5 | 1.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 0.5 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.5 | 2.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.5 | 1.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.5 | 2.2 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.5 | 3.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.5 | 11.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 1.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.5 | 1.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.5 | 1.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 1.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.5 | 2.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 1.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 0.5 | GO:0015677 | copper ion import(GO:0015677) |
0.5 | 3.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.5 | 4.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.5 | 0.5 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.5 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 2.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.5 | 1.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.5 | 2.7 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.5 | 5.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 1.6 | GO:0002591 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.5 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.5 | 24.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.5 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 1.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.5 | 0.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.5 | 3.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 1.6 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.5 | 7.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.5 | 1.6 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.5 | 1.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.5 | 4.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.5 | 3.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.5 | 0.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.5 | 2.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 1.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.5 | 2.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.5 | 1.0 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.5 | 6.7 | GO:0051693 | actin filament capping(GO:0051693) |
0.5 | 0.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.5 | 2.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.5 | 0.5 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.5 | 1.0 | GO:0046499 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) S-adenosylmethioninamine metabolic process(GO:0046499) |
0.5 | 4.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.5 | 1.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.5 | 5.6 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.5 | 5.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.5 | 35.1 | GO:0006457 | protein folding(GO:0006457) |
0.5 | 1.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.5 | 0.5 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 0.5 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.5 | 2.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 6.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.5 | 1.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.5 | 1.5 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.5 | 0.5 | GO:0019042 | viral latency(GO:0019042) |
0.5 | 2.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 1.0 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.5 | 0.5 | GO:2000679 | positive regulation of transcription regulatory region DNA binding(GO:2000679) |
0.5 | 4.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 2.0 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.5 | 0.5 | GO:0097531 | mast cell migration(GO:0097531) |
0.5 | 2.0 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.5 | 4.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.5 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.5 | 2.0 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.5 | 2.5 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.5 | 1.0 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 5.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.5 | 9.4 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.5 | 3.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.5 | 3.5 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.5 | 6.9 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.5 | 2.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 2.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.5 | 1.5 | GO:0015819 | lysine transport(GO:0015819) |
0.5 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 9.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.5 | 4.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.5 | 1.0 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.5 | 2.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 6.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.5 | 1.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 1.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.5 | 1.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.5 | 7.8 | GO:0001562 | response to protozoan(GO:0001562) |
0.5 | 4.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 1.5 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.5 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.5 | 1.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.5 | 1.4 | GO:0043084 | penile erection(GO:0043084) |
0.5 | 2.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.5 | 1.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.5 | 3.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 1.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.5 | 3.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.5 | 0.5 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.5 | 0.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.5 | 0.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.5 | 0.9 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.5 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.5 | 0.5 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.5 | 3.8 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.5 | 0.9 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.5 | 1.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 0.5 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.5 | 8.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.5 | 0.9 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.5 | 1.9 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.5 | 1.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 3.7 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.5 | 0.9 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.5 | 6.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 0.9 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.5 | 0.5 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.5 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 1.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 1.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.5 | 1.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 1.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 0.5 | GO:0051029 | rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
0.5 | 1.4 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.5 | 0.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.5 | 0.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.5 | 0.9 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.5 | 1.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.5 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 1.8 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 1.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.5 | 3.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.5 | 5.9 | GO:0051591 | response to cAMP(GO:0051591) |
0.5 | 0.9 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.5 | 3.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.5 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.5 | 11.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.5 | 0.5 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 6.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 0.9 | GO:0009620 | response to fungus(GO:0009620) |
0.4 | 2.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.4 | 0.9 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.4 | 2.2 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.4 | 1.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 2.2 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.4 | 8.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.4 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.4 | 0.4 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.4 | 1.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 0.9 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 1.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 0.4 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.4 | 1.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.4 | 2.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.4 | 0.9 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.4 | 0.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.4 | 1.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.4 | 6.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 1.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.4 | 0.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 3.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.4 | 0.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 2.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.4 | 1.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.4 | 2.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 2.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 0.9 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.4 | 1.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.4 | 0.9 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.4 | 1.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.4 | 2.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 3.8 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.4 | 0.9 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 0.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.4 | 2.5 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.4 | 2.1 | GO:0055076 | transition metal ion homeostasis(GO:0055076) |
0.4 | 1.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 2.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 0.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.4 | 0.4 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.4 | 3.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.4 | 0.4 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.4 | 0.8 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.4 | 9.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 0.8 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.4 | 0.8 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.4 | 2.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.4 | 0.8 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.4 | 2.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 0.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 24.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.4 | 2.0 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 0.4 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.4 | 0.4 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.4 | 1.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 0.8 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.4 | 2.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 2.8 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.4 | 7.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.4 | 7.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.4 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 1.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 4.4 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.4 | 2.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.4 | 2.7 | GO:0010043 | response to zinc ion(GO:0010043) |
0.4 | 2.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 1.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.4 | 2.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.4 | 1.2 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 1.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.4 | 4.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 3.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.4 | 0.8 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.4 | 0.4 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 2.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 3.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.4 | 0.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.4 | 1.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 0.8 | GO:0044838 | cell quiescence(GO:0044838) |
0.4 | 10.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.4 | 2.7 | GO:0030168 | platelet activation(GO:0030168) |
0.4 | 0.4 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 1.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 0.4 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.4 | 0.4 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.4 | 0.4 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.4 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 9.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.4 | 1.9 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.4 | 6.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.4 | 0.4 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.4 | 0.8 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.4 | 1.9 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.4 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 0.7 | GO:0007129 | synapsis(GO:0007129) |
0.4 | 1.9 | GO:0071569 | protein ufmylation(GO:0071569) |
0.4 | 0.7 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.4 | 0.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 1.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 3.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.4 | 1.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.4 | 1.5 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.4 | 4.8 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.4 | 1.1 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.4 | 0.7 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.4 | 1.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 4.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.4 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 4.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 0.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 1.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 0.4 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.4 | 4.6 | GO:0030239 | myofibril assembly(GO:0030239) |
0.4 | 1.1 | GO:0015817 | histidine transport(GO:0015817) |
0.4 | 0.4 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.4 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.4 | 2.8 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.4 | 2.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.4 | 0.7 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.4 | 0.4 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.4 | 0.7 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.4 | 2.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.4 | 2.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.3 | 1.7 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 0.7 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.3 | 1.7 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 1.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.3 | 1.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.7 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.3 | 0.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 2.1 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.3 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 0.3 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.3 | 0.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.3 | 0.3 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.3 | 1.0 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.3 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 1.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 5.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.3 | 4.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.3 | 0.7 | GO:0006833 | water transport(GO:0006833) |
0.3 | 1.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 2.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 0.7 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.3 | 0.3 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.3 | 0.3 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.3 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 4.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 0.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 11.7 | GO:0007599 | hemostasis(GO:0007599) |
0.3 | 0.7 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.3 | 1.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 0.3 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.3 | 2.3 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 3.0 | GO:0002534 | cytokine production involved in inflammatory response(GO:0002534) |
0.3 | 3.3 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.3 | 2.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 1.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.3 | 1.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 0.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 6.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 1.3 | GO:0036035 | osteoclast development(GO:0036035) |
0.3 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 1.9 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.3 | 0.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.3 | 1.6 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.3 | 0.3 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.3 | 0.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 0.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 | 0.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 2.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.3 | 0.3 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.3 | 0.9 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.3 | 0.9 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.3 | GO:0021571 | rhombomere 4 development(GO:0021570) rhombomere 5 development(GO:0021571) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 1.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 1.8 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.3 | 1.2 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.3 | 2.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 1.5 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.3 | 7.6 | GO:0001824 | blastocyst development(GO:0001824) |
0.3 | 9.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 2.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.3 | 0.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 1.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 1.8 | GO:0061515 | myeloid cell development(GO:0061515) |
0.3 | 0.9 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 0.6 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.3 | 0.9 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.3 | 0.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 0.6 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.3 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.3 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.3 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.3 | 0.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 2.3 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.3 | 0.6 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 5.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 1.2 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.3 | 4.8 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.3 | 0.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 1.1 | GO:0046456 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.3 | 1.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 1.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 1.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 3.6 | GO:0016575 | histone deacetylation(GO:0016575) |
0.3 | 0.3 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.3 | 0.6 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 0.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.3 | 8.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.3 | 0.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 5.2 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.3 | 0.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 0.5 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.3 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 7.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 3.8 | GO:0060323 | head morphogenesis(GO:0060323) |
0.3 | 0.5 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 1.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 0.3 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.5 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.3 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 0.5 | GO:0048599 | oocyte development(GO:0048599) |
0.3 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 1.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.3 | 0.5 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.3 | 0.3 | GO:0001781 | neutrophil apoptotic process(GO:0001781) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 0.3 | GO:0031100 | organ regeneration(GO:0031100) |
0.3 | 1.0 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.3 | 3.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.3 | 6.3 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.3 | 7.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 0.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.2 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.2 | 2.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 2.7 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 1.0 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.2 | 1.9 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 1.2 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.2 | 0.7 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.2 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.2 | 0.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 3.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.2 | 5.0 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 1.9 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.2 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:1901563 | response to camptothecin(GO:1901563) |
0.2 | 0.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 2.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.5 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.2 | 1.1 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 41.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 15.1 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.2 | 1.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 2.0 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.2 | 0.4 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 0.9 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 9.5 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.2 | 12.7 | GO:0006869 | lipid transport(GO:0006869) |
0.2 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 3.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.4 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 0.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.2 | 1.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 1.1 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 0.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 3.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 0.2 | GO:0046939 | nucleotide phosphorylation(GO:0046939) |
0.2 | 6.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 4.9 | GO:0009060 | aerobic respiration(GO:0009060) |
0.2 | 1.3 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.4 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.2 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 0.8 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.2 | 1.7 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.2 | 0.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 0.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 3.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.2 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.2 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.2 | 0.4 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 0.6 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) |
0.2 | 2.0 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.2 | 2.1 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.2 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 1.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.6 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.2 | 2.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 1.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 0.4 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.2 | 0.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.2 | GO:0065001 | proximal/distal axis specification(GO:0009946) specification of axis polarity(GO:0065001) |
0.2 | 1.5 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 2.6 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.2 | 1.5 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.2 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.6 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.2 | 1.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.2 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.2 | 1.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 1.3 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 1.9 | GO:0043627 | response to estrogen(GO:0043627) |
0.2 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 1.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.2 | 0.3 | GO:0002337 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.2 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 7.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.2 | 0.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 1.0 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.2 | 0.2 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.2 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 0.5 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.2 | 0.2 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.2 | 0.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.2 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.2 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 1.6 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 1.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.2 | 0.2 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.2 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.6 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.2 | 1.4 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.2 | 0.5 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.2 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 0.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.9 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.2 | 0.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 2.8 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.2 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 3.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 3.2 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.1 | 1.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.4 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 11.7 | GO:0002237 | response to molecule of bacterial origin(GO:0002237) |
0.1 | 0.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.1 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
0.1 | 0.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 3.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 3.8 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 1.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.8 | GO:0071901 | negative regulation of MAP kinase activity(GO:0043407) negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.1 | 0.7 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 1.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.1 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.1 | 1.2 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.9 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.7 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.8 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 6.5 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.6 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.6 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 9.0 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.1 | 0.2 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.1 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.1 | 0.9 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 4.0 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.5 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.1 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.1 | 0.1 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 1.2 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.1 | 1.7 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.1 | GO:0032277 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.4 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.1 | 0.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 1.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 0.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 1.1 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 3.9 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 1.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.1 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 1.7 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.1 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 4.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.4 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.4 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 6.5 | GO:0007283 | spermatogenesis(GO:0007283) |
0.1 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 1.0 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 1.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.2 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.0 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.2 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.0 | 0.0 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.0 | 0.0 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 2.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 1.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 29.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 4.6 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.6 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.1 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
3.5 | 3.5 | GO:0033269 | internode region of axon(GO:0033269) |
3.2 | 9.7 | GO:0097513 | myosin II filament(GO:0097513) |
3.2 | 15.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
3.1 | 9.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.0 | 9.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.0 | 14.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.9 | 14.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.9 | 5.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.8 | 11.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.7 | 8.1 | GO:0097443 | sorting endosome(GO:0097443) |
2.5 | 7.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.5 | 12.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.4 | 18.9 | GO:0005861 | troponin complex(GO:0005861) |
2.3 | 11.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.3 | 7.0 | GO:0031523 | Myb complex(GO:0031523) |
2.3 | 37.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.2 | 11.2 | GO:0005638 | lamin filament(GO:0005638) |
2.2 | 4.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.2 | 6.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
2.2 | 8.8 | GO:0000322 | storage vacuole(GO:0000322) |
2.2 | 6.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.2 | 10.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
2.2 | 6.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.2 | 6.5 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.2 | 8.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.1 | 8.3 | GO:0071203 | WASH complex(GO:0071203) |
2.1 | 10.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.0 | 10.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.0 | 10.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.0 | 6.0 | GO:1990423 | RZZ complex(GO:1990423) |
2.0 | 21.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.0 | 7.9 | GO:0072487 | MSL complex(GO:0072487) |
2.0 | 5.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.9 | 5.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.9 | 5.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.9 | 13.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.9 | 5.7 | GO:0097413 | Lewy body(GO:0097413) |
1.8 | 11.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.8 | 16.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.8 | 24.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.8 | 7.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.8 | 7.0 | GO:0016459 | myosin complex(GO:0016459) |
1.7 | 7.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.7 | 8.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.7 | 10.3 | GO:0030056 | hemidesmosome(GO:0030056) |
1.7 | 6.8 | GO:0005642 | annulate lamellae(GO:0005642) |
1.7 | 10.2 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.7 | 11.8 | GO:0042382 | paraspeckles(GO:0042382) |
1.7 | 11.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.7 | 5.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.7 | 8.3 | GO:0030870 | Mre11 complex(GO:0030870) |
1.7 | 3.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.6 | 3.2 | GO:0032010 | phagolysosome(GO:0032010) |
1.6 | 4.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.6 | 11.0 | GO:0031931 | TORC1 complex(GO:0031931) |
1.5 | 4.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.5 | 4.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.5 | 12.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.5 | 9.1 | GO:0090543 | Flemming body(GO:0090543) |
1.5 | 3.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.5 | 7.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.5 | 4.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.5 | 5.9 | GO:0005916 | fascia adherens(GO:0005916) |
1.5 | 1.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.5 | 20.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.5 | 21.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.5 | 8.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.4 | 5.7 | GO:1990130 | Iml1 complex(GO:1990130) |
1.4 | 4.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.4 | 4.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.4 | 5.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.4 | 5.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.4 | 5.6 | GO:0097470 | ribbon synapse(GO:0097470) |
1.4 | 2.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.4 | 75.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.4 | 18.1 | GO:0043034 | costamere(GO:0043034) |
1.4 | 12.5 | GO:0042641 | actomyosin(GO:0042641) |
1.4 | 2.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.4 | 11.0 | GO:0070652 | HAUS complex(GO:0070652) |
1.4 | 15.0 | GO:0002102 | podosome(GO:0002102) |
1.4 | 4.1 | GO:0097452 | GAIT complex(GO:0097452) |
1.3 | 4.0 | GO:0044194 | cytolytic granule(GO:0044194) |
1.3 | 6.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.3 | 3.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.3 | 3.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.3 | 9.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.3 | 15.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.3 | 22.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.3 | 24.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.3 | 3.8 | GO:0032437 | cuticular plate(GO:0032437) |
1.3 | 7.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.3 | 1.3 | GO:0016939 | kinesin II complex(GO:0016939) |
1.3 | 28.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.3 | 3.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.3 | 6.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.3 | 10.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.2 | 6.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.2 | 6.1 | GO:0070820 | tertiary granule(GO:0070820) |
1.2 | 4.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
1.2 | 26.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.2 | 1.2 | GO:0061574 | ASAP complex(GO:0061574) |
1.2 | 15.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.2 | 3.6 | GO:0005745 | m-AAA complex(GO:0005745) |
1.2 | 7.1 | GO:0042587 | glycogen granule(GO:0042587) |
1.2 | 2.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.2 | 8.3 | GO:0045179 | apical cortex(GO:0045179) |
1.2 | 1.2 | GO:0042827 | platelet dense granule(GO:0042827) |
1.2 | 4.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.2 | 4.7 | GO:0035339 | SPOTS complex(GO:0035339) |
1.2 | 26.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.2 | 11.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.1 | 63.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.1 | 8.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.1 | 3.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.1 | 3.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.1 | 4.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.1 | 9.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.1 | 3.4 | GO:0097542 | ciliary tip(GO:0097542) |
1.1 | 6.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.1 | 6.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.1 | 1.1 | GO:0030689 | Noc complex(GO:0030689) |
1.1 | 34.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.1 | 12.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.1 | 6.5 | GO:0042629 | mast cell granule(GO:0042629) |
1.1 | 1.1 | GO:0016342 | catenin complex(GO:0016342) |
1.1 | 3.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.1 | 10.7 | GO:0031430 | M band(GO:0031430) |
1.1 | 6.4 | GO:0034709 | methylosome(GO:0034709) |
1.1 | 14.9 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
1.1 | 5.3 | GO:0033263 | CORVET complex(GO:0033263) |
1.1 | 4.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.1 | 5.3 | GO:0031143 | pseudopodium(GO:0031143) |
1.1 | 29.5 | GO:0005776 | autophagosome(GO:0005776) |
1.0 | 3.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.0 | 1.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.0 | 21.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.0 | 1.0 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.0 | 83.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.0 | 5.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
1.0 | 86.6 | GO:0072562 | blood microparticle(GO:0072562) |
1.0 | 4.0 | GO:0005795 | Golgi stack(GO:0005795) |
1.0 | 2.0 | GO:0005683 | U7 snRNP(GO:0005683) |
1.0 | 5.0 | GO:0030914 | STAGA complex(GO:0030914) |
1.0 | 3.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.0 | 5.0 | GO:0043203 | axon hillock(GO:0043203) |
1.0 | 16.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
1.0 | 7.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.0 | 8.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.0 | 3.9 | GO:0031970 | organelle envelope lumen(GO:0031970) |
1.0 | 3.9 | GO:0070938 | contractile ring(GO:0070938) |
1.0 | 1.0 | GO:0016460 | myosin II complex(GO:0016460) |
1.0 | 3.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.0 | 3.8 | GO:0042825 | TAP complex(GO:0042825) |
1.0 | 9.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.9 | 16.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.9 | 6.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 0.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.9 | 6.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.9 | 9.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.9 | 6.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 9.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.9 | 13.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.9 | 6.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 3.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.9 | 5.5 | GO:0042599 | lamellar body(GO:0042599) |
0.9 | 10.0 | GO:0031672 | A band(GO:0031672) |
0.9 | 2.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.9 | 1.8 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.9 | 45.3 | GO:0005811 | lipid particle(GO:0005811) |
0.9 | 35.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.9 | 1.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.9 | 4.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 19.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.9 | 11.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.9 | 4.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.9 | 0.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.9 | 2.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.9 | 0.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.9 | 36.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.9 | 11.3 | GO:0036038 | MKS complex(GO:0036038) |
0.9 | 1.7 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 49.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.9 | 5.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.9 | 34.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.9 | 2.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.9 | 18.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.9 | 5.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.8 | 1.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.8 | 4.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.8 | 9.3 | GO:0046930 | pore complex(GO:0046930) |
0.8 | 2.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 9.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 6.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 34.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.8 | 2.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.8 | 6.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.8 | 2.4 | GO:1990923 | PET complex(GO:1990923) |
0.8 | 0.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.8 | 2.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.8 | 2.4 | GO:0005770 | late endosome(GO:0005770) |
0.8 | 3.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.8 | 4.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.8 | 2.3 | GO:0044299 | C-fiber(GO:0044299) |
0.8 | 2.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.8 | 2.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.8 | 2.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.8 | 1.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.8 | 3.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.8 | 3.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.8 | 20.6 | GO:0016592 | mediator complex(GO:0016592) |
0.8 | 3.0 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.8 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.7 | 188.6 | GO:0005924 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
0.7 | 6.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 5.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 5.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.7 | 2.9 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.7 | 9.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.7 | 2.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.7 | 2.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.7 | 3.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.7 | 8.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.7 | 2.8 | GO:0098536 | deuterosome(GO:0098536) |
0.7 | 17.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.7 | 5.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.7 | 4.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 29.6 | GO:0016605 | PML body(GO:0016605) |
0.7 | 1.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.7 | 78.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.7 | 4.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.7 | 2.8 | GO:0000938 | GARP complex(GO:0000938) |
0.7 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.7 | 2.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.7 | 2.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 8.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.7 | 7.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.7 | 4.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.7 | 2.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 2.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.7 | 4.0 | GO:0036452 | ESCRT complex(GO:0036452) |
0.7 | 2.0 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.7 | 1.3 | GO:0032009 | early phagosome(GO:0032009) |
0.7 | 2.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.7 | 3.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.6 | 1.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 0.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.6 | 1.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.6 | 4.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 17.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.6 | 7.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.6 | 5.5 | GO:0043196 | varicosity(GO:0043196) |
0.6 | 3.0 | GO:0051286 | cell tip(GO:0051286) |
0.6 | 3.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.6 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 1.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 4.8 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.6 | 7.8 | GO:0000786 | nucleosome(GO:0000786) |
0.6 | 19.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.6 | 1.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 1.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.6 | 1.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.6 | 2.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 4.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.6 | 0.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.6 | 11.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.6 | 4.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.6 | 0.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 4.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.6 | 1.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.6 | 12.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.6 | 0.6 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.6 | 23.0 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.6 | 1.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 5.0 | GO:1990391 | DNA repair complex(GO:1990391) |
0.6 | 2.2 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 10.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.6 | 4.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.6 | 3.3 | GO:0031415 | NatA complex(GO:0031415) |
0.6 | 14.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.5 | 1.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.5 | 4.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 2.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 3.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 8.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.5 | 2.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 0.5 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.5 | 2.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 3.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 50.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 3.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 0.5 | GO:1990462 | omegasome(GO:1990462) |
0.5 | 4.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.6 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 21.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.5 | 6.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 3.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.5 | 2.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.5 | 12.9 | GO:0030118 | clathrin coat(GO:0030118) |
0.5 | 4.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.5 | 12.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.5 | 17.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 2.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 1.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.5 | 53.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.5 | 22.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 1.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 3.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.5 | 1.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.5 | 4.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.5 | 23.8 | GO:0031674 | I band(GO:0031674) |
0.5 | 8.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 2.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 1.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.5 | 4.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.5 | 1.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.5 | 135.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.5 | 4.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.5 | 22.5 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.5 | 2.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.5 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 0.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 2.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.5 | 4.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.5 | 136.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.5 | 1.4 | GO:0032982 | myosin filament(GO:0032982) |
0.5 | 29.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.5 | 1.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 1.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.5 | 14.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.5 | 3.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 2.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 1.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 2.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 8.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.4 | 509.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.4 | 7.0 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 2.6 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 9.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.4 | 21.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.4 | 1.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 0.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 7.9 | GO:0030496 | midbody(GO:0030496) |
0.4 | 37.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 4.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 23.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 5.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 13.9 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 1.2 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 11.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 3.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 0.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 16.6 | GO:0005938 | cell cortex(GO:0005938) |
0.4 | 1.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 0.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.4 | 9.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 1.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 26.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.4 | 8.8 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 3.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 13.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 0.4 | GO:0030120 | vesicle coat(GO:0030120) |
0.4 | 18.7 | GO:0005903 | brush border(GO:0005903) |
0.4 | 2.1 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 8.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.3 | 0.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 213.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 1.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 2.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 2.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 8.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 3.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 1.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 0.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 0.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 1.5 | GO:1904949 | ATPase complex(GO:1904949) |
0.3 | 1.5 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 4.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 2.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 2.0 | GO:0016234 | inclusion body(GO:0016234) |
0.3 | 0.8 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 1.4 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 1.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 4.0 | GO:0043292 | contractile fiber(GO:0043292) |
0.3 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.3 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.3 | 28.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 148.9 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 2.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 45.0 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 12.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 0.5 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 1.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 10.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 2.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 202.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 13.2 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 2.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 3.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 15.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 7.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.9 | GO:0044452 | nucleolar part(GO:0044452) |
0.1 | 6.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 4.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 63.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.9 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 14.1 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.5 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 62.6 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
4.7 | 4.7 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
4.7 | 4.7 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
4.4 | 13.1 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
4.1 | 12.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
4.0 | 12.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
4.0 | 12.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.7 | 25.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
3.7 | 14.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.6 | 10.9 | GO:0030172 | troponin C binding(GO:0030172) |
3.6 | 10.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
3.3 | 23.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
3.3 | 22.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.3 | 9.8 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
3.2 | 12.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.0 | 9.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.0 | 11.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.0 | 14.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
2.9 | 14.7 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
2.9 | 11.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.8 | 8.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.8 | 8.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.8 | 2.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.8 | 13.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.8 | 16.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.6 | 2.6 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
2.6 | 7.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.6 | 7.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
2.6 | 2.6 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
2.5 | 2.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
2.5 | 7.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.5 | 2.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.5 | 12.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.5 | 12.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.4 | 19.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.4 | 7.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
2.4 | 4.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.4 | 9.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.4 | 2.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
2.3 | 9.4 | GO:0009374 | biotin binding(GO:0009374) |
2.3 | 9.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.3 | 11.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.3 | 6.8 | GO:0019961 | interferon binding(GO:0019961) |
2.3 | 27.2 | GO:0044548 | S100 protein binding(GO:0044548) |
2.3 | 13.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.2 | 11.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
2.2 | 6.6 | GO:0051373 | FATZ binding(GO:0051373) |
2.2 | 15.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
2.2 | 6.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.2 | 6.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.2 | 2.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.2 | 23.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
2.2 | 4.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
2.2 | 25.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
2.1 | 6.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.1 | 6.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.1 | 12.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.1 | 12.4 | GO:0043426 | MRF binding(GO:0043426) |
2.1 | 8.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.1 | 2.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.0 | 24.6 | GO:0017166 | vinculin binding(GO:0017166) |
2.0 | 2.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
2.0 | 6.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.0 | 14.1 | GO:0018631 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
2.0 | 2.0 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
2.0 | 6.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.0 | 8.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.0 | 9.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
2.0 | 5.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.0 | 7.9 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
2.0 | 5.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.9 | 5.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.9 | 19.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.9 | 5.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.9 | 1.9 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
1.9 | 7.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.9 | 11.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.8 | 14.6 | GO:0008430 | selenium binding(GO:0008430) |
1.8 | 1.8 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.8 | 5.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.8 | 16.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.8 | 3.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.8 | 8.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.8 | 14.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.8 | 3.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.7 | 5.2 | GO:1990188 | euchromatin binding(GO:1990188) |
1.7 | 12.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.7 | 1.7 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.7 | 10.4 | GO:0031432 | titin binding(GO:0031432) |
1.7 | 1.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.7 | 3.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.7 | 10.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.7 | 1.7 | GO:0070538 | oleic acid binding(GO:0070538) |
1.7 | 15.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.7 | 8.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.7 | 6.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.7 | 5.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.7 | 6.7 | GO:0046790 | virion binding(GO:0046790) |
1.7 | 25.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.7 | 24.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.7 | 8.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.7 | 6.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.7 | 9.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.6 | 4.9 | GO:0031014 | troponin T binding(GO:0031014) |
1.6 | 1.6 | GO:0070191 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) methionine-R-sulfoxide reductase activity(GO:0070191) |
1.6 | 4.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.6 | 4.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.6 | 4.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.6 | 6.5 | GO:0043515 | kinetochore binding(GO:0043515) |
1.6 | 11.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.6 | 9.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.6 | 1.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.6 | 6.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.6 | 4.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.6 | 6.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.6 | 4.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.6 | 4.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.6 | 3.1 | GO:0015928 | fucosidase activity(GO:0015928) |
1.6 | 4.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.5 | 12.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.5 | 6.2 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.5 | 3.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.5 | 3.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.5 | 7.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.5 | 7.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.5 | 9.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.5 | 6.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.5 | 4.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.5 | 4.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.5 | 4.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.5 | 4.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.5 | 9.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.5 | 4.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.5 | 3.0 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
1.5 | 6.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.5 | 7.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.5 | 14.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.5 | 5.9 | GO:0015232 | heme transporter activity(GO:0015232) |
1.5 | 4.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.5 | 1.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.5 | 1.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.4 | 4.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.4 | 4.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.4 | 5.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.4 | 1.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.4 | 11.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.4 | 8.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.4 | 11.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.4 | 11.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
1.4 | 5.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.4 | 2.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.4 | 12.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.4 | 4.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.4 | 8.3 | GO:0015288 | porin activity(GO:0015288) |
1.4 | 17.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.4 | 5.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.4 | 5.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.4 | 5.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.4 | 4.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.4 | 6.8 | GO:0070728 | leucine binding(GO:0070728) |
1.4 | 4.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.4 | 4.1 | GO:0048030 | disaccharide binding(GO:0048030) |
1.4 | 2.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.3 | 13.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.3 | 9.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.3 | 8.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.3 | 9.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.3 | 4.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.3 | 2.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.3 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.3 | 3.9 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.3 | 11.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.3 | 5.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
1.3 | 1.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.3 | 11.6 | GO:0018448 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.3 | 1.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.3 | 3.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.3 | 7.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.3 | 2.6 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
1.3 | 1.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
1.3 | 2.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.3 | 19.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.3 | 20.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.3 | 2.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.3 | 5.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.3 | 11.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.3 | 3.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.2 | 1.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.2 | 2.5 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
1.2 | 1.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.2 | 13.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.2 | 24.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.2 | 7.4 | GO:0050733 | RS domain binding(GO:0050733) |
1.2 | 3.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.2 | 11.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.2 | 4.9 | GO:0043559 | insulin binding(GO:0043559) |
1.2 | 20.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.2 | 4.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.2 | 14.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.2 | 4.8 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.2 | 4.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.2 | 3.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.2 | 3.6 | GO:0030519 | snoRNP binding(GO:0030519) |
1.2 | 4.8 | GO:0030274 | LIM domain binding(GO:0030274) |
1.2 | 7.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.2 | 8.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.2 | 3.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.2 | 1.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.2 | 5.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.2 | 18.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.2 | 5.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.2 | 9.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.2 | 3.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.2 | 9.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.2 | 8.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.2 | 3.5 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.2 | 4.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.2 | 12.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.2 | 3.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.2 | 4.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.2 | 5.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.2 | 1.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.2 | 13.8 | GO:0005123 | death receptor binding(GO:0005123) |
1.1 | 9.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.1 | 3.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.1 | 3.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.1 | 4.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.1 | 6.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.1 | 1.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.1 | 42.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.1 | 12.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.1 | 10.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.1 | 3.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.1 | 3.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.1 | 3.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.1 | 6.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 5.5 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
1.1 | 3.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.1 | 3.3 | GO:0048038 | quinone binding(GO:0048038) |
1.1 | 9.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.1 | 1.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
1.1 | 6.6 | GO:0050700 | CARD domain binding(GO:0050700) |
1.1 | 6.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.1 | 3.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.1 | 16.3 | GO:0008143 | poly(A) binding(GO:0008143) |
1.1 | 4.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.1 | 4.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.1 | 15.1 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 1.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
1.1 | 2.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.1 | 1.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.1 | 2.1 | GO:2001070 | starch binding(GO:2001070) |
1.1 | 13.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.1 | 20.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.1 | 29.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.1 | 7.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.1 | 12.7 | GO:0005542 | folic acid binding(GO:0005542) |
1.1 | 3.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.1 | 9.5 | GO:0031996 | thioesterase binding(GO:0031996) |
1.1 | 3.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.1 | 3.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.0 | 2.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.0 | 5.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.0 | 3.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.0 | 5.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.0 | 3.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.0 | 4.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 6.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.0 | 3.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.0 | 14.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.0 | 2.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
1.0 | 4.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.0 | 3.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.0 | 7.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
1.0 | 3.0 | GO:0055100 | adiponectin binding(GO:0055100) |
1.0 | 12.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.0 | 3.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.0 | 9.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.0 | 19.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.0 | 1.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.0 | 19.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.0 | 4.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.0 | 6.9 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.0 | 2.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.0 | 4.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.0 | 4.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.0 | 3.9 | GO:0002046 | opsin binding(GO:0002046) |
1.0 | 3.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.0 | 4.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.0 | 8.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.0 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.0 | 4.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.0 | 1.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.0 | 9.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.0 | 10.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.0 | 25.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.0 | 2.9 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.0 | 2.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.0 | 4.8 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
1.0 | 7.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.0 | 5.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.0 | 13.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.0 | 1.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.9 | 1.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 3.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.9 | 11.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.9 | 1.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.9 | 2.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.9 | 13.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.9 | 11.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.9 | 44.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.9 | 7.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.9 | 4.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.9 | 15.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.9 | 7.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.9 | 2.8 | GO:0070061 | fructose binding(GO:0070061) |
0.9 | 9.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.9 | 15.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.9 | 2.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.9 | 1.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.9 | 2.7 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.9 | 0.9 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.9 | 4.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.9 | 0.9 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.9 | 3.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.9 | 2.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 3.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.9 | 3.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.9 | 15.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 4.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.9 | 1.8 | GO:0031433 | telethonin binding(GO:0031433) |
0.9 | 3.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.9 | 11.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.9 | 9.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 2.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.9 | 4.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.9 | 2.6 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.9 | 10.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.9 | 15.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.9 | 3.4 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.9 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.9 | 3.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.9 | 4.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.9 | 0.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.8 | 4.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.8 | 8.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.8 | 1.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.8 | 5.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.8 | 2.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.8 | 1.7 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.8 | 0.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.8 | 1.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.8 | 3.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.8 | 2.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.8 | 1.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.8 | 2.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.8 | 2.5 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.8 | 3.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.8 | 5.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.8 | 1.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 2.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.8 | 2.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.8 | 10.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.8 | 4.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 1.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.8 | 15.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.8 | 4.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.8 | 1.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.8 | 3.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.8 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 15.9 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.8 | 16.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.8 | 2.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.8 | 3.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.8 | 5.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.8 | 3.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.8 | 3.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.8 | 4.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.8 | 3.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.8 | 0.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.8 | 3.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.8 | 4.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.8 | 2.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.8 | 2.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.8 | 29.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.8 | 2.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.8 | 0.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.8 | 1.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.8 | 25.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.8 | 4.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.8 | 2.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 2.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.8 | 9.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.8 | 0.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.8 | 3.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.7 | 2.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.7 | 18.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.7 | 7.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.7 | 11.9 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 6.0 | GO:0019176 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.7 | 4.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 0.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 4.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.7 | 2.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.7 | 20.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.7 | 2.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.7 | 11.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.7 | 3.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.7 | 1.5 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.7 | 31.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.7 | 2.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.7 | 10.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.7 | 7.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.7 | 11.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 1.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.7 | 1.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.7 | 2.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.7 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 2.1 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 2.9 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.7 | 1.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 2.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.7 | 4.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 0.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.7 | 4.2 | GO:0005536 | glucose binding(GO:0005536) |
0.7 | 2.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.7 | 2.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 14.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.7 | 2.8 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.7 | 8.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.7 | 3.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.7 | 18.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.7 | 4.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.7 | 12.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.7 | 6.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.7 | 2.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.7 | 13.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.7 | 5.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.7 | 4.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.7 | 6.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.7 | 2.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.7 | 0.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.7 | 1.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.7 | 2.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.7 | 2.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.7 | 18.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.7 | 10.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 2.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.7 | 2.0 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.7 | 8.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.7 | 8.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.7 | 2.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.7 | 7.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.7 | 1.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.7 | 6.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 3.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 58.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.7 | 5.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.6 | 3.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.6 | 0.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.6 | 8.4 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.6 | 7.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.6 | 2.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 5.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 3.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.6 | 15.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 1.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.6 | 3.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 1.9 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 2.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 18.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.6 | 6.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.6 | 1.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 4.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 0.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.6 | 4.9 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.6 | 6.7 | GO:0010181 | FMN binding(GO:0010181) |
0.6 | 3.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 4.3 | GO:0035586 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) purinergic receptor activity(GO:0035586) |
0.6 | 1.8 | GO:0038100 | nodal binding(GO:0038100) |
0.6 | 1.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.6 | 4.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.6 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 5.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.6 | 7.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 17.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 2.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.6 | 15.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.6 | 2.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 1.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 5.2 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.6 | 1.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 3.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.6 | 4.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.6 | 3.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 4.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.6 | 3.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 4.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 2.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 2.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.6 | 1.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 14.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 2.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.6 | 9.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.6 | 1.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.6 | 8.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 14.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.6 | 18.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.6 | 4.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.5 | 2.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 8.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 2.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.5 | 2.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.5 | 11.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.5 | 3.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 4.4 | GO:0046977 | TAP binding(GO:0046977) |
0.5 | 1.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 3.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 1.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.5 | 9.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.5 | 1.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.5 | 1.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 4.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.5 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 4.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.5 | 6.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 0.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 17.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 5.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.5 | 2.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 5.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 6.3 | GO:0043531 | ADP binding(GO:0043531) |
0.5 | 13.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.5 | 6.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.5 | 3.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 3.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 4.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.5 | 1.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 5.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 5.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 24.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.5 | 4.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.5 | 2.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 1.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.5 | 8.5 | GO:0001848 | complement binding(GO:0001848) |
0.5 | 0.5 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.5 | 14.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.5 | 1.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 32.7 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.5 | 1.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.5 | 5.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 1.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.5 | 1.0 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.5 | 1.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.5 | 5.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.5 | 3.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 4.3 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.5 | 10.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.5 | 1.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 5.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 1.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 35.2 | GO:0005178 | integrin binding(GO:0005178) |
0.5 | 2.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.5 | 1.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 2.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 5.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.5 | 1.4 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.5 | 3.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 0.9 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.5 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.5 | 1.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.5 | 5.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 1.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 5.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.5 | 0.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.5 | 4.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 1.8 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.5 | 1.8 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 15.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 2.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 7.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 4.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.4 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 0.9 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 14.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 5.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 0.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.4 | 2.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 0.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 5.7 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 1.3 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.4 | 0.4 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.4 | 20.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 9.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 1.3 | GO:0016726 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.4 | 1.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.3 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.4 | 0.8 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.4 | 1.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 6.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 39.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.4 | 3.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 1.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 1.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 8.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 6.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.4 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 0.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.4 | 7.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.4 | 1.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 1.2 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 1.2 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 2.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 2.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.4 | 12.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.4 | 12.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 2.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 8.1 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 10.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.4 | 4.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.4 | 1.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 0.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 3.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 49.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.4 | 4.8 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 3.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 3.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 4.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.4 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.4 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 2.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 4.6 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) DNA-N1-methyladenine dioxygenase activity(GO:0043734) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.4 | 2.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 8.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.4 | 4.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.4 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 17.9 | GO:0015923 | mannosidase activity(GO:0015923) |
0.4 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 3.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 39.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 1.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.4 | 1.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 34.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.4 | 1.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.4 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 25.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.4 | 26.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.4 | 1.5 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 1.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 4.4 | GO:0004601 | peroxidase activity(GO:0004601) |
0.4 | 14.2 | GO:0017022 | myosin binding(GO:0017022) |
0.4 | 62.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 12.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.4 | 0.7 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 4.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.4 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 1.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 2.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 4.6 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.4 | 1.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 1.4 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.3 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 6.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 0.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 1.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 0.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 0.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.3 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 3.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.3 | 1.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.7 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.3 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 11.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 0.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 1.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 3.8 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.3 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 2.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 8.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 0.9 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.3 | 1.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.3 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 0.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 1.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 7.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 2.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 20.0 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.3 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 2.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 1.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 2.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 9.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 4.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.3 | 58.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.3 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.3 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.3 | 0.8 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 2.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 4.2 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.3 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 1.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 5.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 0.5 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.3 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 5.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.3 | 0.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 0.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.3 | 1.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.3 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 1.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 1.8 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.3 | 5.5 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.3 | 2.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 51.9 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 1.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 2.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 2.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 0.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 2.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 5.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 3.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 4.4 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.2 | 15.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 0.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 10.5 | GO:0019902 | phosphatase binding(GO:0019902) |
0.2 | 3.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 1.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 2.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 6.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 2.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 0.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.7 | GO:0046332 | SMAD binding(GO:0046332) |
0.2 | 0.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 1.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 9.7 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 7.3 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 2.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 100.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 1.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 8.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 0.6 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 31.1 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 2.4 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.2 | 0.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 1.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 1.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.0 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.5 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 1.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 0.6 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 2.7 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 2.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 3.2 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 2.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 3.4 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 0.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 1.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.5 | GO:0051431 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 0.2 | GO:0015927 | trehalase activity(GO:0015927) |
0.2 | 0.5 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 1.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 1.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 1.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 1.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 1.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 21.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
0.1 | 2.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 2.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 12.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 7.1 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 4.8 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 10.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 2.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.6 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 1.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.3 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 3.7 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.1 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 2.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.7 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 5.0 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 4.2 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 45.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 6.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 11.6 | GO:0046914 | transition metal ion binding(GO:0046914) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 2.7 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 19.1 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 4.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
3.1 | 27.5 | ST STAT3 PATHWAY | STAT3 Pathway |
2.5 | 2.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
2.5 | 58.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.8 | 75.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.8 | 23.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.8 | 110.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.7 | 1.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.7 | 23.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.6 | 3.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.6 | 38.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.5 | 25.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.5 | 53.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.5 | 3.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.5 | 1.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.5 | 11.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.4 | 2.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.4 | 9.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.4 | 2.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.3 | 12.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.3 | 16.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.3 | 7.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.3 | 41.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.3 | 3.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.3 | 11.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.3 | 56.7 | PID P73PATHWAY | p73 transcription factor network |
1.3 | 54.0 | PID P53 REGULATION PATHWAY | p53 pathway |
1.3 | 28.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.2 | 16.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.2 | 12.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.2 | 47.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.2 | 28.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.2 | 21.1 | PID IFNG PATHWAY | IFN-gamma pathway |
1.2 | 9.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.2 | 47.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.2 | 18.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.2 | 20.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.1 | 17.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.1 | 32.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.1 | 9.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.1 | 5.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.0 | 24.1 | PID RHOA PATHWAY | RhoA signaling pathway |
1.0 | 14.0 | PID MYC PATHWAY | C-MYC pathway |
1.0 | 43.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.9 | 19.8 | PID ATM PATHWAY | ATM pathway |
0.9 | 22.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.9 | 26.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.9 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 0.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.9 | 6.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.9 | 15.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.9 | 4.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.9 | 24.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.9 | 6.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.8 | 30.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.8 | 13.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.8 | 3.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.8 | 43.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.8 | 13.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.8 | 20.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.8 | 1.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.8 | 8.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 23.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.8 | 5.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 1.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 0.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.8 | 12.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.8 | 13.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.8 | 12.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.7 | 5.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.7 | 3.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.7 | 10.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.7 | 13.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 15.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.7 | 2.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.7 | 1.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.7 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.7 | 23.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.7 | 7.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.7 | 38.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 9.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 14.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 6.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.6 | 3.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.6 | 10.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.6 | 9.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 10.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.6 | 3.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 8.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.6 | 6.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 6.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.6 | 3.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.6 | 1.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 1.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 4.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 8.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 2.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 1.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 2.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 9.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 6.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 2.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 2.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 6.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 7.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 1.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 7.3 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 2.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 6.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 7.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.4 | 4.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 4.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 2.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 4.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 1.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 2.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 2.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 1.8 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 1.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 6.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 63.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 2.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 2.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 3.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 6.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 5.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 1.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 3.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 3.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 1.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 1.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 3.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 2.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 3.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 2.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 1.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 18.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 4.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 35.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
3.6 | 3.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
3.0 | 6.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
2.9 | 23.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
2.6 | 13.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.4 | 24.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.4 | 9.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
2.3 | 25.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.3 | 36.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
2.2 | 22.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.2 | 49.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
2.1 | 19.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.1 | 10.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
2.1 | 2.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
2.0 | 32.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.0 | 19.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.8 | 25.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.8 | 19.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.8 | 1.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.7 | 17.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.7 | 34.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.7 | 18.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.6 | 22.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.6 | 13.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.6 | 22.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.6 | 17.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.6 | 35.8 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
1.5 | 38.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.5 | 22.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.5 | 19.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.5 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.4 | 21.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.4 | 42.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.4 | 20.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.4 | 11.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.4 | 16.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.3 | 12.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.3 | 1.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.3 | 9.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
1.3 | 14.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.3 | 1.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.3 | 20.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.3 | 21.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.3 | 12.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
1.3 | 17.7 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
1.3 | 3.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.3 | 7.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.2 | 29.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.2 | 1.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.2 | 8.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.2 | 10.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.2 | 1.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.2 | 11.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.1 | 43.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.1 | 3.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.1 | 10.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.1 | 3.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
1.1 | 15.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.1 | 30.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.1 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.1 | 38.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.1 | 12.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.1 | 23.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.1 | 25.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.1 | 12.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.1 | 17.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.1 | 69.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.1 | 9.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.1 | 81.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.0 | 11.5 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
1.0 | 3.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.0 | 65.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.0 | 8.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.0 | 3.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.0 | 3.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.0 | 5.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.0 | 5.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.0 | 4.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.0 | 6.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.0 | 8.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.9 | 14.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.9 | 5.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.9 | 13.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.9 | 20.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.9 | 19.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.9 | 3.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.9 | 3.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.9 | 2.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.9 | 9.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.9 | 17.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.9 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.9 | 1.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.8 | 19.5 | REACTOME MAP KINASE ACTIVATION IN TLR CASCADE | Genes involved in MAP kinase activation in TLR cascade |
0.8 | 3.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.8 | 10.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.8 | 5.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.8 | 23.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.8 | 21.5 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.8 | 15.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.8 | 5.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.8 | 4.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.8 | 23.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 8.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.7 | 6.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.7 | 6.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.7 | 10.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.7 | 5.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 4.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 8.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.7 | 12.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.7 | 3.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.7 | 7.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 2.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.7 | 4.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.7 | 0.7 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.7 | 10.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.7 | 6.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 4.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 7.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.7 | 9.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.7 | 2.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.6 | 13.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 14.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 3.9 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.6 | 5.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 27.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.6 | 23.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 4.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 11.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 5.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.6 | 8.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.6 | 1.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.6 | 27.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 1.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.6 | 16.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.6 | 13.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.6 | 4.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.6 | 7.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.6 | 2.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.6 | 2.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.6 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 16.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.6 | 4.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.6 | 23.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.6 | 7.9 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.6 | 2.8 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.6 | 5.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 3.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.6 | 7.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 46.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.5 | 5.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.5 | 11.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.5 | 2.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.5 | 7.9 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.5 | 3.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 4.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.5 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 3.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 21.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.5 | 13.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.5 | 2.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 1.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 11.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.5 | 12.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.5 | 11.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 1.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 4.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 18.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 13.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 6.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 1.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 3.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.4 | 0.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.4 | 4.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 37.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 2.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.4 | 10.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 2.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 2.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 2.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.4 | 4.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.4 | 2.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 11.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 0.8 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 1.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.4 | 8.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 5.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 3.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 9.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 3.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 9.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 6.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 7.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 38.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 7.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.3 | 2.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 14.8 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.3 | 3.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 4.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 1.0 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.3 | 9.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 23.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 20.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 1.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 1.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 2.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 0.3 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.3 | 1.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 1.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 5.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 6.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 3.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 1.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 1.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 5.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 4.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 8.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 3.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 3.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 8.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 2.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 0.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 2.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 4.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 5.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 1.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 0.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 3.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 1.8 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 2.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.4 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.5 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |